We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVAC
2951
DELISTED
Intevac Inc
IVAC
$127K ﹤0.01%
22,994
-910
-4% -$5.25K
BOCH
2952
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$127K ﹤0.01%
18,247
+14,312
+364% +$106K
FENC icon
2953
Fennec Pharmaceuticals
FENC
$419M
$126K ﹤0.01%
20,807
+19,631
+1,669% +$138K
MIRM icon
2954
Mirum Pharmaceuticals
MIRM
$6.04B
$126K ﹤0.01%
6,536
+5,376
+463% +$115K
MRSN
2955
DELISTED
Mersana Therapeutics
MRSN
$126K ﹤0.01%
272
-108
-28% -$54.6K
PRTA icon
2956
Prothena Corp
PRTA
$457M
$126K ﹤0.01%
12,558
+3,359
+37% +$40.4K
PSL icon
2957
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.3M
$126K ﹤0.01%
1,654
-37,408
-96% -$2.77M
RSP icon
2958
Invesco S&P 500 Equal Weight ETF
RSP
$100B
$126K ﹤0.01%
1,164
-4,670
-80% -$504K
SGMO
2959
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$126K ﹤0.01%
13,349
-13,070
-49% -$141K
MIDF
2960
DELISTED
iShares MSCI USA Mid-Cap Multifactor ETF
MIDF
$126K ﹤0.01%
4,640
+4,614
+17,746% +$124K
PTVCB
2961
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$126K ﹤0.01%
9,633
+7,793
+424% +$112K
BBWI icon
2962
Bath & Body Works
BBWI
$3.9B
$125K ﹤0.01%
4,874
-481
-9% -$9.83K
CFFI icon
2963
C&F Financial
CFFI
$289M
$125K ﹤0.01%
4,190
+2,699
+181% +$83.9K
CMCT
2964
Creative Media & Community Trust
CMCT
$14.3M
$125K ﹤0.01%
+1
New +$258K
CBIO
2965
Crescent Biopharma
CBIO
$613M
$125K ﹤0.01%
406
+332
+449% +$127K
SPR
2966
DELISTED
Spirit AeroSystems
SPR
$125K ﹤0.01%
6,562
-22,278
-77% -$470K
UVSP icon
2967
Univest Financial
UVSP
$1.19B
$125K ﹤0.01%
8,733
+5,056
+138% +$78.6K
VRCA icon
2968
Verrica Pharmaceuticals
VRCA
$85.9M
$125K ﹤0.01%
1,615
+1,348
+505% +$110K
PZN
2969
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$125K ﹤0.01%
23,373
+17,743
+315% +$92.8K
CKPT
2970
DELISTED
Checkpoint Therapeutics
CKPT
$124K ﹤0.01%
4,639
+3,840
+481% +$92.2K
CUBE icon
2971
CubeSmart
CUBE
$9.4B
$124K ﹤0.01%
3,834
-11,774
-75% -$356K
FBIZ icon
2972
First Business Financial Services
FBIZ
$597M
$124K ﹤0.01%
8,689
+6,832
+368% +$106K
HWBK icon
2973
Hawthorn Bancshares
HWBK
$277M
$124K ﹤0.01%
7,348
+5,918
+414% +$95.6K
LCUT icon
2974
Lifetime Brands
LCUT
$224M
$124K ﹤0.01%
13,099
+10,177
+348% +$87.6K
RYZ
2975
Ryerson Holding Corp
RYZ
$1.49B
$124K ﹤0.01%
21,757
+16,688
+329% +$96.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.